Mercury Biopharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	166.09	44.29	31.94	2.56	0.09	0.15
Short-Term Investments	98.8	284.78	108.7	-	-	-
Cash & Short-Term Investments	264.89	329.07	140.64	2.56	0.09	0.15
Cash Growth	-25.71%	133.99%	5391.45%	2877.91%	-43.79%	-
Other Receivables	3.99	3.76	2.46	-	-	-
Receivables	3.99	3.76	2.46	-	-	-
Prepaid Expenses	6.39	6.54	2.64	-	0.01	0
Other Current Assets	0.24	0.55	-	1.37	-	-
Total Current Assets	275.51	339.93	145.73	3.93	0.1	0.16
Property, Plant & Equipment	88.61	79.94	75.15	8.46	-	-
Other Intangible Assets	3.14	2.71	0.5	0.49	-	-
Other Long-Term Assets	11.55	15.5	8.55	0.51	-	-
Total Assets	378.81	438.08	229.93	13.38	0.1	0.16
Accrued Expenses	2.32	5.06	4.61	0.66	0.01	-
Short-Term Debt	-	-	-	-	0.3	0.15
Current Portion of Leases	0.27	0.68	1.05	0.79	-	-
Current Unearned Revenue	5.73	0.44	-	-	-	-
Other Current Liabilities	4.9	1.87	1.57	0.26	-	0.01
Total Current Liabilities	13.4	8.05	7.23	1.7	0.31	0.16
Long-Term Debt	41.43	41.6	41.6	-	-	-
Long-Term Leases	0.08	0.07	0.77	1.22	-	-
Total Liabilities	54.9	49.72	49.6	2.93	0.31	0.16
Common Stock	104.36	103.99	100.87	15.4	0.2	0.2
Additional Paid-In Capital	281.86	328.17	110.72	0.37	-	-
Retained Earnings	-18.31	-43.82	-31.25	-5.31	-0.41	-0.2
Comprehensive Income & Other	3.04	0.01	-	-	-	-
Shareholders' Equity	323.91	388.35	180.33	10.46	-0.21	0
Total Liabilities & Equity	378.81	438.08	229.93	13.38	0.1	0.16
Total Debt	41.95	42.35	43.42	2.01	0.3	0.15
Net Cash (Debt)	222.94	286.73	97.21	0.55	-0.21	0
Net Cash Growth	-28.93%	194.94%	17575.09%	-	-	-
Net Cash Per Share	0.54	0.70	0.26	0.00	-0.00	-
Filing Date Shares Outstanding	414.5	415.96	403.46	403.46	104	-
Total Common Shares Outstanding	414.5	415.96	403.46	307.94	104	-
Working Capital	262.12	331.88	138.5	2.22	-0.21	0
Book Value Per Share	0.78	0.93	0.45	0.03	-0.00	-
Tangible Book Value	320.77	385.65	179.83	9.97	-0.21	0
Tangible Book Value Per Share	0.77	0.93	0.45	0.03	-0.00	-
Land	41.9	41.9	41.9	-	-	-
Buildings	18.12	18.12	18.12	-	-	-
Machinery	21.66	15.05	6.42	5.88	-	-
Construction In Progress	12.02	7.25	7.5	-	-	-
Leasehold Improvements	0.91	0.91	0.91	0.91	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.